Proteases in parasitic diseases

Annual Review of Pathology

Volumn 1, Issue , 2006, Pages 497-536

  McKerrow, James H ^a   Caffrey, Conor ^a   Kelly, Ben ^a   Loke, P'ng ^a   Sajid, Mohammed ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Host; Immune response; Invasion; Parasite; Protease inhibitor

Indexed keywords

CRUZIPAIN; CYSTATIN; CYSTEINE PROTEINASE; HEMOGLOBIN; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

APICOMPLEXA; ASCARIS; CELL INVASION; ENTAMOEBA HISTOLYTICA; INFLAMMATION; LEISHMANIA; PARASITE MIGRATION; PARASITOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTOZOON; REVIEW; TRYPANOSOMA CRUZI; WORM;

EID: 33645744855     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathol.1.110304.100151     Document Type: Review

References (208)

1. Special Programme for Research and Training in Tropical Diseases. 2004. http://www. who.int/tdr/tropics
2. Barrett AJ. 2004. Bioinformatics of proteases in the MEROPS database. Curr. Opin. Drug Discov. Dev. 7:334-41
3. Sakanari JA. 1990. Anisakis-from the platter to the microfuge. Parasitol. Today 6:323-27
4. Daschner A, Cuellar C, Sanchez-Pastor S, Pascual CY, Martin-Esteban M. 2002. Gastro-allergic anisakiasis as a consequence of simultaneous primary and secondary immune response. Parasite Immunol. 24:243-51
5. Nakamura-Uchiyama F, Yamasaki E, Nawa Y. 2002. One confirmed and six suspected cases of cutaneous larva migrans caused by overseas infection with dog hookworm larvae. J. Dermatol. 29:104-11
6. Ly MN, Bethel SL, Usmani AS, Lambert DR. 2003. Cutaneous Strongyloides stercoralis infection: an unusual presentation. J. Am. Acad. Dermatol. 49:S157-60
7. Kagialis-Girard S, Mialou V, Ffrench M, Dupuis-Girod S, Pages MP, Bertrand Y. 2005. Thrombocytosis and toxocariasis: report of two pediatric cases. Pediatr. Blood Cancer 44:190-92
8. Tort J, Brindley PJ, Knox D, Wolfe KH, Dalton JP. 1999. Proteinases and associated genes of parasitic helminths. Adv. Parasitol. 43:161-266
9. McKerrow JH, Brindley P, Brown M, Gam AA, Staunton C, Neva FA. 1990. Strongyloides stercoralis: identification of a protease that facilitates penetration of skin by the infective larvae. Exp. Parasitol. 70:134-43
10. Lackey A, James ER, Sakanari JA, Resnick SD, Brown M, et al. 1989. Extracellular proteases of Onchocerca. Exp. Parasitol. 68:176-85
11. Law RH, Smooker PM, Irving JA, Piedrafita D, Ponting R, et al. 2003. Cloning and expression of the major secreted cathepsin B-like protein from juvenile Fasciola hepatica and analysis of immunogenicity following liver fluke infection. Infect. Immun. 71:6921-32
12. Shin MH, Lee SY. 2000. Proteolytic activity of cysteine protease in excretory-secretory product of Paragonimus westermani newly excysted metacercariae pivotally regulates IL-8 production of human eosinophils. Parasite Immunol. 22:529-33
13. Park H, Kim SI, Hong KM, Kim MJ, Shin CH, et al. 2002. Characterization and classification of five cysteine proteinases expressed by Paragonimus westermani adult worm. Exp. Parasitol. 102:143-49
14. Na BK, Lee HJ, Cho SH, Lee HW, Cho JH, et al. 2002. Expression of cysteine proteinase of Clonorchis sinensis and its use in serodiagnosis of clonorchiasis. J. Parasitol. 88:1000-6
15. Yamakami K, Hamajima F, Akao S, Tadakuma T. 1995. Purification and characterization of acid cysteine protease from metacercariae of the mammalian trematode parasite Paragonimus westermani. Eur. J. Biochem. 233:490-97
16. Shin MH, Lee SY. 2000. Proteolytic activity of cysteine protease in excretory-secretory product of Paragonimus westermani newly excysted metacercariae pivotally regulate IL-8 production of human eosinophils. Parasite Immunol. 22:529-33
17. Sung CK, Dresden MH. 1986. Cysteinyl proteinases of Schistosoma mansoni eggs: purification and partial characterization. J. Parasitol. 72:891-900
18. Caffrey CR, McKerrow JH, Salter JP, Sajid M. 2004. Blood 'n' guts: an update on schistosome digestive peptidases. Trends Parasitol. 20:241-48
19. Ruppel A, Shi YE, Wei DX, Diesfeld HJ. 1987. Sera of Schistosoma japonicum-infected patients cross-react with diagnostic 31/32 kD proteins of S. mansoni. Clin. Exp. Immunol. 69:291-98
20. Li YL, Idris MA, Corachan M, HanJJ, Kirschfink M, Ruppel A. 1996. Circulating antigens in schistosomiasis: detection of 31/32-kDa proteins in sera from patients infected with Schistosoma japonicum, S. mansoni, S. haematobium, or S. intercalatum. Parasitol. Res. 82:14-18
21. Yun DH, Chung JY, Chung YB, Bahk YY, Kang SY, et al. 2000. Structural and immunological characteristics of a 28-kilodalton cruzipain-like cysteine protease of Paragonimus westermani expressed in the definitive host stage. Clin. Diagn. Lab. Immunol. 7:932-39
22. Yamasaki K, Ishiyama H, Imaizumi T, Kanbe T, Yabuuchi Y. 1989. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn. J. Pharmacol. 49:441-48
23. Smith AM, Dowd AJ, McGonigle S, Keegan PS, Brennan G, et al. 1993. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol. Biochem. Parasitol. 62:1-8
24. Skelly PJ. 2005. Intravascular schistosomes and complement. Trends Parasitol. In press
25. Salter JP, Choe Y, Albrecht H, Franklin C, Lim KC, et al. 2002. Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes. J. Biol. Chem. 277:24618-24
26. Mountford AP, Trottein F. 2004. Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol. 20:221-26
27. Curwen RS, Wilson RA. 2003. Invasion of skin by schistosome cercariae: some neglected facts. Trends Parasitol. 19:63-66
28. Fishelson Z. 1995. Novel mechanisms of immune evasion by Schistosoma mansoni. Mem. Inst. Orwaldo Cruz 90:289-92
29. Knudsen GM, Medzihradszky KF, Lim KC, Hansell E, McKerrow JH. 2005. Proteomic analysis of Schistosoma mansoni cercarial secretions. Mol. Cell. Proteomics. In press
30. Chang CS, Chang KP. 1986. Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding. Proc. Natl. Acad. Sci. USA 83:100-4
31. Frommel TO, Button LL, Fujikura Y, McMaster WR. 1990. The major surface glycoprotein (GP63) is present in both life stages of Leishmania. Mol. Biochem. Parasitol. 38:25-32
32. Chen DQ, Kolli BK, Yadava N, Lu HG, Gilman-Sachs A, et al. 2000. Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro. Infect. Immun. 68:80-86
33. Joshi PB, Kelly BL, Kamhawi S, Sacks DL, McMaster WR. 2002. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120:33-40
34. Brittingham A, Mosser DM. 1996. Exploitation of the complement system by Leishmania promastigotes. Parasitol. Today 12:444-47
35. Dominguez M, Moreno I, Lopez-Trascasa M, Torano A. 2002. Complement interaction with trypanosomatid promastigotes in normal human serum. J. Exp. Med. 195:451-59
36. McGwire BS, Chang KP, Engman DM. 2003. Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63. Infect. Immun. 71:1008-10
37. Hilley JD, Zawadzki JL, McConville MJ, Coombs GH, Mottram JC. 2000. Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins. Mol. Biol. Cell 11:1183-95
38. Voth BR, Kelly BL, Joshi PB, Ivens AC, McMaster WR. 1998. Differentially expressed Leishmania major gp63 genes encode cell surface leishmanolysin with distinct signals for glycosylphosphatidylinositol attachment. Mol. Biochem. Parasitol. 93:31-41
39. Victoir K, Dujardin JC, de Doncker S, Barker DC, Arevalo J, et al. 1995. Plasticity of gp63 gene organization in Leishmania (Viannia) braziliensis and Leishmania (Viannia) peruviana. Parasitology 111(Pt. 3):265-73
40. Yao C, Luo J, Storlie P, Donelson JE, Wilson ME. 2004. Multiple products of the Leishmania chagasi major surface protease (MSP or GP63) gene family. Mol. Biochem. Parasitol. 135:171-83
41. McConville MJ, Schnur LF, Jaffe C, Schneider P. 1995. Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species. Biochem J. 310(Pt. 3):807-18
42. McConville MJ, Turco SJ, Ferguson MA, Sacks DL. 1992. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J. 11:3593-600
43. Sacks DL. 1992. The structure and function of the surface lipophosphoglycan on different developmental stages of Leishmania promastigotes. Infect Agents Dis. 1:200-6
44. Lincoln LM, Ozaki M, Donelson JE, Beetham JK. 2004. Genetic complementation of Leishmania deficient in PSA (GP46) restores their resistance to lysis by complement. Mol. Biochem. Parasitol. 137:185-89
45. Beverley SM. 2003. Protozomics: trypanosomatid parasite genetics comes of age. Nat. Rev. Genet. 4:11-19
46. Souza AE, Bates PA, Coombs GH, Mottram JC. 1994. Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicana. Mol. Biochem. Parasitol. 63:213-20
47. Bart G, Frame MJ, Carter R, Coombs GH, Mottram JC. 1997. Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana. Mol. Biochem. Parasitol. 88:53-61
48. Mottram JC, Coombs GH, Alexander J. 2004. Cysteine peptidases as virulence factors of Leishmania. Curr. Opin. Microbiol. 7:375-81
49. Mottram JC, Souza AE, Hutchison JE, Carter R, Frame MJ, Coombs GH. 1996. Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sci. USA 93:6008-13
50. Mottram JC, Frame MJ, Brooks DR, Tetley L, Hutchison JE, et al. 1997. The multiple cpb cysteine proteinase genes of Leishmania mexicana encode isoenzymes that differ in their stage regulation and substrate preferences. J. Biol. Chem. 272:14285-93
51. Frame MJ, Mottram JC, Coombs GH. 2000. Analysis of the roles of cysteine proteinases of Leishmania mexicana in the host-parasite interaction. Parasitology 121(Pt. 4):367-77
52. Alexander J, Coombs GH, Mottram JC. 1998. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol. 161:6794-801
53. Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, et al. 2004. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J. Immunol. 173:3297-304
54. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P. 2003. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. J. Immunol. 171:3711-17
55. Fukao T, Matsuda S, Koyasu S. 2000. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J. Immunol. 164:64-71
56. Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, et al. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402-6
57. Stamm LM, Raisanen-Sokolowski A, Okano M, Russell ME, David JR, Satoskar AR. 1998. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J. Immunol. 161:6180-88
58. Tran VQ, Herdman DS, Torian BE, Reed SL. 1998. The neutral cysteine proteinase of Entamoeba histolytica degrades IgG and prevents its binding. J. Infect. Dis. 177:508-11
59. Kelsall BL, Ravdin JI. 1993. Degradation of human IgA by Entamoeba histolytica. J. Infect. Dis. 168:1319-22
60. Olivos-Garcia A, Tello E, Nequiz-Avendano M, Gonzalez-Canto A, Lopez-Vancell R, et al. 2004. Cysteine proteinase activity is required for survival of the parasite in experimental acute amoebic liver abscesses in hamsters. Parasitology 129:19-25
61. Bruchhaus I, Loftus BJ, Hall N, Tannich E. 2003. The intestinal protozoan parasite Entamoeba histolytica contains 20 cysteine protease genes, of which only a small subset is expressed during in vitro cultivation. Eukaryot. Cell 2:501-9
62. Bruchhaus I, Jacobs T, Leippe M, Tannich E. 1996. Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes. Mol. Microbiol. 22:255-63
63. Willhoeft U, Hamann E, Tannich E. 1999. A DNA sequence corresponding to the gene encoding cysteine proteinase 5 in Entamoeba histolytica is present and positionally conserved but highly degenerated in Entamoeba dispar. Infect. Immun. 67:5925-29
64. Hellberg A, Nickel R, Lotter H, Tannich E, Bruchhaus I. 2001. Overexpression of cysteine proteinase 2 in Entamoeba histolytica or Entamoeba dispar increases amoeba-induced monolayer destruction in vitro but does not augment amoebic liver abscess formation in gerbils. Cell. Microbiol. 3:13-20
65. Pertuz Belloso S, Ostoa Saloma P, Benitez I, Soldevila G, Olivos A, Garcia-Zepeda E. 2004. Entamoeba histolytica cysteine protease 2 (EhCP2) modulates leucocyte migration by proteolytic cleavage of chemokines. Parasite Immunol. 26:237-41
66. Ankri S, Stolarsky T, Mirelman D. 1998. Antisense inhibition of expression of cysteine proteinases does not affect Entamoeba histolytica cytopathic or haemolytic activity but inhibits phagocytosis. Mol. Microbiol. 28:777-85
67. Ankri S, Stolarsky T, Bracha R, Padilla-Vaca F, Mirelman D. 1999. Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters. Infect. Immun. 67:421-22
68. Zhang Z, Wang E, Seydel KB, Li E, Ankri S, et al. 2000. Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis. Mol. Microbiol. 37:542-48
69. Que X, Kim SH, Sajid M, Eckmann E, Dinarello CA, et al. 2003. A surface amebic cysteine proteinase inactivates interleukin-18. Infect. Immun. 71:1274-80
70. Kaur G, Lohia A. 2004. Inhibition of gene expression with double strand RNA interference in Entamoeba histolytica. Biochem. Biophys. Res. Commun. 320:1118-22
71. Pleass RJ, Kusel JR, Woof JM. 2000. Cleavage of human IgE mediated by Schistosoma mansoni. Int. Arch. Allergy Immunol. 121:194-204
72. Amiri P, Haak-Frendscho M, Robbins K, McKerrow JH, Stewart T, Jardieu P. 1994. Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice. J. Exp. Med. 180:43-51
73. King CL, Xianli J, Malhotra I, Liu S, Mahmoud AA, Oettgen HC. 1997. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J. Immunol. 158:294-300
74. Spencer LA, Porte P, Zetoff C, Rajan TV. 2003. Mice genetically deficient in immunoglobulin E are more permissive hosts than wild-type mice to a primary, but not secondary, infection with the filarial nematode Brugia malayi. Infect. Immun. 71:2462-67
75. Ghendler Y, Parizade M, Arnon R, McKerrow JH, Fishelson Z. 1996. Schistosoma mansoni: evidence for a 28-kDa membrane-anchored protease on schistosomula. Exp. Parasitol. 83:73-82
76. Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, McKerrow JH. 1998. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J. Cell Sci. 111(Pt. 5):597-606
77. Burleigh BA, Andrews NW. 1995. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu. Rev. Microbiol. 49:175-200
78. Martin D, Tarleton R. 2004. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol. Rev. 201:304-17
79. Engman DM, Leon JS. 2002. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop. 81:123-32
80. Tarleton RL. 2003. Chagas disease: a role for autoimmunity? Trends Parasitol. 19:447-51
81. Scharfstein J, Schmitz V, Morandi V, Capella MM, Lima AP, et al. 2000. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J. Exp. Med. 192:1289-300
82. Aparicio LM, Scharfstein J, Lima AP. 2004. Anew cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 72:5892-902
83. Arnholdt AC, Piuvezam MR, Russo DM, Lima AP, Pedrosa RC, et al. 1993. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J. Immunol. 151:3171-79
84. Kierszenbaum F. 1999. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12:210-23
85. Lozykowski MG, McCormick TS, Rowland EC. 1991. Coincidence of tissue antibody and cardiac pathology in mice infected with Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 85:225-26
86. Laguens RP, Meckert PC, Chambo JG. 1988. Antiheart antibody-dependent cytotoxicity in the sera of mice chronically infected with Trypanosoma cruzi. Infect. Immun. 56:993-97
87. Giordanengo L, Maldonado C, Rivarola HW, Iosa D, Girones N, et al. 2000. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur. J. Immunol. 30:3181-89
88. Giordanengo L, Fretes BL, Diaz H, Cano R, Bacile A, et al. 2000. Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice. Muscle Nerve 23:1407-13
89. Guinazu N, Pellegrini A, Giordanengo L, Aoki MP, Rivarola HW, et al. 2004. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice. Microbes Infect. 6:1250-58
90. Giordanengo L, Guinazu N, Stempin C, Fretes R, Cerban F, Gea S. 2002. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 32:1003-11
91. Gordon S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35
92. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771-77
93. Munder M, Eichmann K, Modolell M. 1998. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160:5347-54
94. Noel W, Raes G, Hassanzadeh Ghassabeh G, De Baetselier P, Beschul A. 2004. Alternatively activated macrophages during parasite infections. Trends Parasitol. 20:126-33
95. Stempin C, Giordanengo L, Gea S, Cerban F. 2002. Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J. Leukoc. Biol. 72:727-34
96. Stempin CC, Tanos TB, Coso OA, Cerban FM. 2004. Arginase induction promotes Trypanosoma cruzi intracellular replication in Cruzipain-treated J774 cells through the activation of multiple signaling pathways. Eur. J. Immunol. 34:200-9
97. Piacenza L, Peluffo G, Radi R. 2001. L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways. Prof. Natl. Acad. Sci. USA 98:7301-6
98. McKerrow JH, McGrath ME, Engel JC. 1995. The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. Parasitol. Today 11:279-82
99. Engel JC, Doyle PS, Hsieh I, McKerrow JH. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-34
100. Engel JC, Torres C, Hsieh I, Doyle PS, McKerrow JH, Garcia CT. 2000. Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi. J. Cell Sci. 113(Pt. 8):1345-S4
101. Vaena de Avalos S, Blader IJ, Fisher M, Boothroyd JC, Burleigh BA. 2002. Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 277:639-44
102. Maizels RM, Gomez-Escobar N, Gregory WF, Murray J, Zang X. 2001. Immune evasion genes from filarial nematodes. Int. J. Parasitol. 31:889-98
103. Pearce EJ, Kane CM, Sun J, Taylor JJ, McKee AS, Cervi L. 2004. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol. Rev. 201:117-26
104. Harnett W, Harnett MM. 2001. Modulation of the host immune system by phosphorylcholine-containing glycoproteins secreted by parasitic filarial nematodes. Biochim. Biophys. Acta 1539:7-15
105. Al-Qaoud KM, Fleischer B, Hoerauf A. 1998. The Xid defect imparts susceptibility to experimental murine filariosis-association with a lack of antibody and IL-10 production by B cells in response to phosphorylcholine. Int. Immunol. 10:17-25
106. Pastrana DV, Raghavan N, FitzGerald P, Eisinger SW, Metz G, et al. 1998. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect. Immun. 66:5955-63
107. Hartmann S, Lucias R. 2003. Modulation of host immune response by nematode cystatins. Int. J. Parasitol. 33:1291-302
108. 107a. Hartmann S, Kyewski B, Sonnenburg B, Lucius R. 1997. A filarial cysteine protease inhibitor down regulates T cell proliferation and enhances interleukin 10 production. Eur. J. Immunol. 27:2253-60
109. Zang X, Maizels RM. 2001. Serine proteinase inhibitors from nematodes and the arms race between host and pathogen. Trends Biochem. Sci. 26:191-97
110. MEROPS the Peptidase Database. Release 7.10. http://merops.sanger.ac.uk
111. Abrahamson M, Alvarez-Fernandez M, Nathanson CM. 2003. Cystatins. Biochem. Soc. Symp. 70:179-99
112. Lustigman S, Brotman B, Huima T, Prince AM, McKerrow JH. 1992. Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J. Biol. Chem. 267:17339-46
113. Manoury B, Gregory WF, Maizels RM, Watts C. 2001. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr. Biol. 11:447-51
114. Pfaff AW, Schulz-Key H, Soboslay PT, Taylor DW, MacLennan K, Hoffmann WH. 2002. Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis. Int. J. Parasitol. 32:171-78
115. Newlands GF, Skuce PJ, Knox DP, Smith WD. 2001. Cloning and expression of cystatin, a potent cysteine protease inhibitor from the gut of Haemonchus contortus. Parasitology 122:371-78
116. Dainichi T, Maekawa Y, Ishii K, Himeno K. 2001. Molecular cloning of a cystatin from parasitic intestinal nematode, Nippostrongylus brasiliensis. J. Med. Invest. 48:81-87
117. Genome Sequencing Center. 2003. http://www.nematode.net
118. Schonemeyer A, Lucius R, Sonnenburg B, Brattig N, Sabat R, et al. 2001. Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus. J. Immunol. 167:3207-15
119. Murray J, Manoury B, Balic A, Watts C, Maizels RM. 2005. Bm-CPI-2, a cystatin from Brugia malayi nematode parasites, differs from Caenorhabditis elegans cystatins in a specific site mediating inhibition of the antigen-processing enzyme AEP. Mol. Biochem. Parasitol. 139:197-203
120. Nakagawa TY, Rudensky AY. 1999. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172:121-29
121. Antoniou AN, Blackwood SL, Mazzeo D, Watts C. 2000. Control of antigen presentation by a single protease cleavage site. Immunity 12:391-98
122. Pierre P, Mellman I. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93:1135-45
123. Watts C, Moss CX, Mazzeo D, West MA, Matthews SP, Li DN. 2003. Creation versus destruction of T cell eptitopes in the class II MHC pathway. Ann. NY Acad. Sci. 987:9-14
124. Mahanty S, Mollis SN, Ravichandran M, Abrams JS, Kumaraswami V, et al. 1996. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J. Infect. Dis. 173:769-73
125. Osborne J, Devaney E. 1999. Interleukin-10 and antigen-presenting cells actively suppress Th1 cells in BALB/c mice infected with the filarial parasite Brugia pahangi. Infect. Immun. 67:1599-605
126. Schierack P, Lucius R, Sonnenburg B, Schilling K, Hartmann S. 2003. Parasite-specific immunomodulatory functions of filarial cystatin. Infect. Immun. 71:2422-29
127. Roberts TH, Hejgaard J, Saunders NF, Cavicchioli R, Curmi PM. 2004. Serpins in unicellular Eukarya, Archaea, and Bacteria: sequence analysis and evolution. J. Mol. Evol. 59:437-47
128. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, et al. 2001. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276:33293-96
129. Huntington JA, Read RJ, Carrell RW. 2000. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407:923-26
130. Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, et al. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186:739-47
131. Padrines M, Wolf M, Walz A, Baggiolini M. 1994. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352:231-35
132. Murohara T, Guo JP, Lefer AM. 1995. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. J. Pharmacol. Exp. Ther: 274:1246-53
133. Tremblay GM, Janelle MF, Bourbonnais Y. 2003. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr. Opin. Investig. Drugs 4:556-65
134. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, et al. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69:597-604
135. Lucas A, Dai E, Liu L, Guan H, Nash P, et al. 2000. Transplant vasculopathy: viral anti-inflammatory serpin regulation of atherogenesis. J. Heart Lung Transpl. 19:1029-38
136. Yenbutr P, Scott AL. 1995. Molecular cloning of a serine proteinase inhibitor from Brugia malayi. Infect. Immun. 63:1745-53
137. Zang X, Yazdanbakhsh M, Jiang H, Kanost MR, Maizels RM. 1999. A novel serpin expressed by blood-borne microfilariae of the parasitic nematode Brugia malayi inhibits human neutrophil serine proteinases. Blood 94:1418-28
138. Stanley P, Stein PE. 2003. BmSPN2, a serpin secreted by the filarial nematode Brugia malayi, does not inhibit human neutrophil proteinases but plays a noninhibitory role. Biochemistry 42:6241-48
139. Stein PE, Tewkesbury DA, Carrell RW. 1989. Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem. J. 262:103-7
140. Dafforn TR, Della M, Miller AD. 2001. The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis. J. Biol. Chem. 276:49310-19
141. Ghendler Y, Arnon R, Fishelson Z. 1994. Schistosoma mansoni: isolation and characterization of Smpi56, a novel serine protease inhibitor. Exp. Parasitol. 78:121-31
142. Modha J, Roberts MC, Kusel JR. 1996. Schistosomes and serpins: A complex business. Parasitol. Today 12:119-21
143. Blanton RE, Licate LS, Aman RA. 1994. Characterization of a native and recombinant Schistosoma haematobium serine protease inhibitor gene product. Mol. Biochem. Parasitol. 63:1-11
144. Huang W, Haas TA, Biesterfeldt J, Mankawsky L, Blanton RE, Lee X. 1999. Purification and crystallization of a novel membrane-anchored protein: the Schistosoma haematobium serpin. Acta Crystallogr. D 55(Pt. 1):350-52
145. Freudenstein-Dan A, Gold D, Fishelson Z. 2003. Killing of schistosomes by elastase and hydrogen peroxide: implications for leukocyte-mediated schistosome killing. J. Parasitol. 89:1129-35
146. Fraefel W, Acher R. 1968. The amino acid sequence of a trypsin inhibitor isolated from ascaris (Ascaris lumbricoides var. suum). Biochim. Biophys. Acta 154:615-17
147. Babin DR, Peanasky RJ, Goos SM. 1984. The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: the primary structure. Arch. Biochem. Biophys. 232:143-61
148. Peanasky RJ, Bentz Y, Paulson B, Graham DL, Babin DR. 1984. The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: isolation by affinity chromatography and association with the enzymes. Arch. Biochem. Biophys. 232:127-34
149. Grasberger BL, Clore GM, Gronenborn AM. 1994. High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. Structure 2:669-78
150. Huang K, Streynadka NC, Bernard VD, Peanasky RJ, James MN. 1994. The molecular structure of the complex Ascaris chymotrypsin/elastase inhibitor with porcine elastase. Structure 2:679-89
151. Duggan BM, Dyson HJ, Wright PE. 1999. Inherent flexibility in a potent inhibitor of blood coagulation, recombinant nematode anticoagulant protein c2. Eur. J. Biochem. 265:539-48
152. Martzen MR, Geise GL, Hogan BJ, Peanasky RJ. 1985. Ascaris suum: localization by immunochemical and fluorescent probes of host proteases and parasite proteinase inhibitors in cross-sections. Exp. Parasitol. 60:139-49
153. Lu CC, Nguyen T, Morris S, Hill D, Sakanari JA. 1998. Anisakis simplex: mutational bursts in the reactive site centers of serine protease inhibitors from an ascarid nematode. Exp. Parasitol. 89:257-61
154. Rhoads ML, Fetterer RH, Hill DE, Urban JF Jr. 2000. Trichuris suis: a secretory chymotrypsin/elastase inhibitor with potential as an immunomodulator. Exp. Parasitol. 95:36-44
155. Bania J, Stachowiak D, Polanowski A. 1999. Primary structure and properties of the cathepsin G/chymotrypsin inhibitor from the larval hemolymph of Apis mellifera. Eur. J. Biochem. 262:680-87
156. Mignogna G, Pascarella S, Wechselberger C, Hinterleitner C, Mollay C, et al. 1996. BSTI, a trypsin inhibitor from skin secretions of Bombina bombina related to protease inhibitors of nematodes. Protein Sci. 5:357-62
157. Vlasuk GP, Rote WE. 2002. Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant. Trends Cardiovasc. Med. 12:325-31
158. Loeb L, Smith AJ. 1904. The presence of a substance inhibiting the coagulation of blood in anchylostoma. Proc. Natl. Acad. Sci. USA 7:173-78
159. Cappello M, Clyne LP, McPhedran P, Hotez PJ. 1993. Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro. J. Infect. Dis. 167:1474-77
160. Cappello M, Vlasuk GP, Bergum PW, Huang S, Hotez PJ. 1995. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc. Natl. Acad. Sci. USA 92:6152-56
161. Stassens P, Bergum PW, Gansemans Y, Jespers L, Laroche Y, et al. 1996. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc. Natl. Acad. Sci. USA 93:2149-54
162. Baugh RJ, Broze GJ Jr, Krishnaswamy S. 1998. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J. Biol. Chem. 273:4378-86
163. Mieszczanek J, Harrison LM, Vlasuk GP, Cappello M. 2004. Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol. Biochem. Parasitol. 133:319-23
164. Mieszczanek J, Harrison LM, Cappello M. 2004. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Mol. Biochem. Parasitol. 137:151-59
165. Harrison LM, Nerlinger A, Bungiro RD, Cordova JL, Kuzmic P, Cappello M. 2002. Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo. J. Biol. Chem. 277:6223-39
166. Rep BH. 1980. Pathogenicity of hookworms. The significance of population regression for the pathogenicity of hookworms. Trop. Geogr. Med. 32:251-55
167. Vlasuk GP, Bradbury A, Lopez-Kinninger L, Colon S, Bergum PW, et al. 2003. Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X. Thromb. Haemost. 90:803-12
168. Lee A, Agnelli G, Buller H, Ginsberg J, Heit J, et al. 2001. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 104:74-78
169. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, et al. 2001. Prevention of venous thromboembolism. Chest 119:8132-75
170. Leander BS, Clopton RE, Keeling PJ. 2003. Phylogeny of gregarines (Apicomplexa) as inferred from small-subunit rDNA and beta-tubulin. Int. J. Syst. Evol. Microbiol. 53:345-54
171. Sibley LD. 2004. Intracellular parasite invasion strategies. Science 304:248-53
172. Soldati D, Meissner M. 2004. Toxoplasma as a novel system for motility. Curr. Opin. Cell Biol. 16:32-40
173. Binder EM, Kim K. 2004. Location, location, location: trafficking and function of secreted proteases of toxoplasma and Plasmodium. Traffic 5:914-24
174. Kim K, Weiss LM. 2004. Toxoplasma gondii: the model apicomplexan. Int. J. Parasitol. 34:423-32
175. Blackman MJ. 2004. Proteases in host cell invasion by the malaria parasite. Cell. Microbiol. 6:893-903
176. Opitz C, Di Cristina M, Reiss M, Ruppert T, Crisanti A, Soldati D. 2002. Intramembrane cleavage of microneme proteins at the surface of the apicomplexan parasite Toxoplasma gondii. EMBO J. 21:1577-85
177. Carruthers VB, Sherman GD, Sibley LD. 2000. The Toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases. J. Biol. Chem. 275:14346-53
178. Miller SA, Binder EM, Blackman MJ, Carruthers VB, Kim K. 2001. A conserved subtilisin-like protein TgSUB1 in microneme organelles of Toxoplasma gondii. J. Biol. Chem. 276:45341-48
179. Miller SA, Thathy V, Ajioka JW, Blackman MJ, Kim K. 2003. TgSUB2 is a Toxoplasma gondii rhoptry organelle processing proteinase. Mol. Microbiol. 49:883-94
180. Uzureau P, Barale JC, Janse CJ, Waters AP, Breton CB. 2004. Gene targeting demonstrates that the Plasmodium berghei subtilisin PbSUB2 is essential for red cell invasion and reveals spontaneous genetic recombination events. Cell. Microbiol. 6:65-78
181. Holder AA, Blackman MJ. 1994. What is the function of MSP-1 on the malaria merzoite? Parasitol. Today 10:182-84
182. Kappe SHI, Buscaglia CA, Bergman LW, Crabb BS, Coppens I, Nussenzweig V. 2004. Apicomplexan gliding motility and host cell invasion: overhauling the motor model. Trends Parasitol. 20:13-16
183. Sultan AA. 1999. Molecular mechanisms of malaria sporozoite motility and invasion of host cells. Int. Microbiol. 2:155-60
184. Silvie O, Franetich JF, Renia L, Mazier D. 2004. Malaria sporozoite: migrating for a living. Trends Mol. Med. 10:97-100
185. Dowse T, Soldati D. 2004. Host cell invasion by the apicomplexans: the significance of microneme protein proteolysis. Curr. Opin. Microbiol. 7:388-96
186. Louie K, Nordhausen R, Robinson TW, Barr BC, Conrad PA. 2002. Characterization of Neospora caninum protease, NcSUB1 (NC-p65), with rabbit anti-N54. J. Parasitol. 88:1113-19
187. Fuller AL, McDougald LR. 1990. Reduction in cell entry of Eimeria tenella (Coccidia) sporozoites by protease inhibitors, and partial characterization of proteolytic activity associated with intact sporozoites and merozoites. J. Parasitol. 76:464-67
188. Greenbaum DC, Baruch A, Grainger M, Bozdech Z, Medzihradszky KF, et al. 2002. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298:2002-6
189. Eski S, Czesny B, Greenbaum DC, Boygo M, Williamson KC. 2004. argeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth. Mol. Microbiol. 53:243-50
190. Grellier P, Picard I, Bernard F, Mayer R, Heidrich HG, et al. 1989. Purification and identification of a neutral endopeptidase in Plasmodium falciparum schizonts and merozoites. Parasitol. Res. 75:455-60
191. Howell SA, Well I, Fleck SL, Kettleborough C, Collins CR, Blackman MJ. 2003. A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. J. Biol. Chem. 278:23890-98
192. Withers-Martinez C, Jean L, Blackman MJ. 2004. Subtilisin-like proteases of the malaria parasite. Mol. Microbiol. 53:55-63
193. Shaw MK, Tilney LG, Musoke AJ. 1991. The entry of Theileria parva sporozoites into bovine lymphocytes: evidence for MHC class I involvement. J. CellBiol. 113:87-101
194. Andrews NW, Portnoy DA. 1994. Cytolysins from intracellular pathogens. Trends Microbiol. 2:261-63
195. Deleted in proof
196. Mota MM, Hafalla JC, Rodriguez A. 2002. Migration through host cells activates Plasmodium sporozoites for infection. Nat. Med. 8:1318-22
197. Coppi A, Pinzon-Ortiz C, Hutter C, Sinnis P. 2005. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J. Exp. Med. 201:27-33
198. Hadley T, Aikawa M, Miller LH. 1983. Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. Exp. Parasitol. 55:306-11
199. Lyon JA, Haynes JD, Diggs CL, Chulay JD, Pratt-Rossiter JM. 1986. Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface by antibodies when schizonts mature in the presence of growth inhibitory immune serum. J. Immunol. 136:2252-58
200. Salmon BL, Oksman A, Goldberg DE. 2001. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc. Natl. Acad. Sci. USA 98:271-76
201. Wickham ME, Culvenor JG, Cowman AF. 2003. Selective inhibition of a two-step egress of malaria parasites from the host erythrocyte. J. Biol. Chem. 278:37658-63
202. Bourgon R, Delorenzi M, Sargeant T, Hodder AN, Crabb BS, Speed TP. 2004. The serine repeat antigen (SERA) gene family phylogeny in Plasmodium: the impact of GC content and reconciliation of gene and species trees. Mol. Biol. Evol. 21:2161-71
203. Miller SK, Good RT, Drew DR, Delorenzi M, Sanders PR, et al. 2002. A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. J. Biol. Chem. 277:47524-32
204. Hanspal M, Dua M, Takakuwa Y, Chishti AH, Mizuno A. 2002. Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100:1048-54
205. Dhawan S, Dua M, Chishti AH, Hanspal M. 2003. Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J. Biol. Chem. 278:30180-86
206. Vernet T, Khouri HE, Laflamme P, Tessier DC, Musil R, et al. 1991. Processing of the papain precursor. J. Biol. Chem. 266:21451-57
207. Hodder AN, Drew DR, Epa VC, Delorenzi M, Bourgon R, et al. 2003. Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5 J. Biol. Chem. 278:48169-77
208. Le Bonniec S, Deregnaucourt C, Redeker V, Banerjee R, Grellier P, et al. 1999. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J. Biol. Chem. 274:14218-23